ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38 | – | 14,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 290,501 | $2,513,000 | 1.83% |
| Knoll Capital Management, LLC | 20,000 | $173,000 | 0.11% |
| Private Portfolio Partners LLC | 42,250 | $365,463 | 0.09% |
| Rossmore Private Capital | 40,661 | $352,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 54,233 | $469,000 | 0.04% |
| Cubist Systematic Strategies, LLC | 241,892 | $2,092,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 662,000 | $5,726,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 550,956 | $4,766,000 | 0.01% |
| Jump Financial, LLC | 34,800 | $301,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 264,824 | $2,291,000 | 0.01% |